BACKGROUND: Patients with peripheral arterial disease (PAD) have increased mortality
compared with patients without PAD. Coronary artery disease (CAD) accounts for almost …

OBJECTIVE To determine the proportion of patients with lower extremity peripheral arterial
disease (PAD) who reach recommended low-density lipoprotein cholesterol (LDL-C) levels …

Peripheral arterial disease (PAD), similar to coronary artery disease (CAD), is a significant
predictor of cardiovascular morbidity and mortality. Guidelines recommend a low-density …

Background Low-density lipoprotein cholesterol (LDL-C) is associated with heightened risk
of major adverse cardiovascular events (MACE) and major adverse limb events (MALE) in …

OBJECTIVE: Our group and others have previously established that patients with peripheral
artery disease (PAD) are significantly undertreated with respect to overall cardiovascular risk …

Background Underutilization of therapies to reduce ischemic risk in peripheral artery
disease (PAD) persists. Objectives The purpose was to conduct an implementation trial of …

Background Underutilization of proven therapies in peripheral artery disease (PAD) persists.
Implementation science may improve this, but few randomized trials exist. We conducted a …

Background Patients with peripheral artery disease (PAD) are at very high risk of future
cardiovascular (CV) events. Strict lipid-lowering therapy is recommended. However, data on …

Effective methods to educate physicians and patients on best medical management are
needed. Further research is needed to examine the benefit of LDL-c lowering and other lipid …

BACKGROUND: The presence of peripheral arterial disease (PAD), even in the absence of
overt coronary artery disease (CAD), confers the same relative risk of death from a …